QuickSTAT Presents a Case Study on Transporting Critical Bulk Drug Substance From China Under Controlled Room Temperature
Case Study Describes How a Pharmaceutical Company Overcame Challenges of Shipping Bulk Drug from China to US
New York, New York (PRWEB) October 14, 2013
QuickSTAT, a leading provider of global life science supply chain solutions, announced the publication of a new case study on a global pharmaceutical company that develops breakthrough treatments for human diseases. The case study describes how the company overcame logistics challenges of shipping bulk drug globally and successfully transported drums of a drug substance from Shanghai, China to a clinical packaging company in the US.
“Managing global export and import requirements, especially from China, where regulations are fluid and often amended can be challenging. It’s important to work with a global transportation provider that has experience with the region and knowledge of best routes,” said Dan Catizone, VP Business Development. “Synchronization of all of the critical elements—from advanced planning and sourcing proper packaging, while verifying that all documentation is accurate will help ensure the integrity of the drug shipment.”
Among the key highlights, the new case study details how QuickSTAT enables biopharmaceutical and research companies conducting clinical trials to accomplish the following:
- Procure appropriate packaging systems
- Monitor temperature throughout transit
- Manage global export and import requirements
- Establish communication protocols
- Minimize delays
- Maintain the integrity of critical shipments
The case study can be freely accessed by visiting: http://quick.aero/quickstat/transporting-critical-bulk-drug-substance/ .
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb11223497.htm